Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine vs Lidocaine for Post-op Pain in Bariatric Surgery
NCT00508976Phase 2Completed
- Sponsor
- UPMC Pinnacle
- Start
- Jun 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bupivacaine and lidocaine in postoperative pain (4 arms), sponsored by UPMC Pinnacle. Primary endpoints: Reduction in post-operative pain at 3 days and Reduction in narcotics usage at 3 days. Started Jun 2007; status: completed.
02
Drugs
bupivacainelidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00508976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00508976.